These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8390257)

  • 1. Degradation of bradykinin in semen of ram and boar.
    Boettger A; Kertscher U; Steinmann C; Baeger U; Siems WE; Heder G
    Biochem Pharmacol; 1993 May; 45(10):1983-8. PubMed ID: 8390257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic degradation of bradykinin in semen of various species.
    Heder G; Bøttger A; Siems WE; Rottmann M; Kertscher U
    Andrologia; 1994; 26(5):295-301. PubMed ID: 7825745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic digestion of bradykinin by rat Sertoli cell cultures.
    Monsees TK; Miska W; Schill WB
    J Androl; 1996; 17(4):375-81. PubMed ID: 8889700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide-metabolizing peptidases in neuro-2a neuroblastoma and C6 glioma cells.
    Del Bel EA; Gambarini AG; Martins AR
    J Neurochem; 1986 Sep; 47(3):938-44. PubMed ID: 3016193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of bradykinin and its metabolites by rat brain synaptic membranes.
    Orawski AT; Simmons WH
    Peptides; 1989; 10(5):1063-73. PubMed ID: 2608554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for neuropeptide-metabolizing peptidases during the differentiation of chick embryo retina.
    Martins AR; De Mello FG
    Brain Res; 1985 Jul; 353(1):147-51. PubMed ID: 2992715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
    Erşahin C; Simmons WH
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P.
    Ahmad S; Ward PE
    Proc Soc Exp Biol Med; 1992 May; 200(1):115-21. PubMed ID: 1315058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N.
    Drapeau G; Chow A; Ward PE
    Peptides; 1991; 12(3):631-8. PubMed ID: 1656406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of kininases in testicular cells.
    Monsees TK; Miska W; Schill WB
    Immunopharmacology; 1996 May; 32(1-3):169-71. PubMed ID: 8796300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin.
    Oliveira EB; Martins AR; Camargo AC
    Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts.
    Vaghy PL; Russell JS; Lantry LE; Stephens RE; Ward PE
    Peptides; 1995; 16(8):1367-73. PubMed ID: 8745045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-turns induced in bradykinin by (S)-alpha-methylproline.
    Welsh JH; Zerbe O; von Philipsborn W; Robinson JA
    FEBS Lett; 1992 Feb; 297(3):216-20. PubMed ID: 1544400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.